NCT04349410 - The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol | Biotech Hunter

Enrollment

1,800

Participants

Timeline

Start Date

April 11, 2020

Primary Completion Date

September 14, 2020

Study Completion Date

September 14, 2020

Conditions

CoVid 19 Positive

Interventions

DRUG

Hydroxychloroquine, Azithromycin

FMTVDM Planar, SPECT, PET

DRUG

Hydroxychloroquine, Doxycycline

FMTVDM Planar, SPECT, PET

DRUG

Hydroxychloroquine, Clindamycin

FMTVDM Planar, SPECT, PET

DRUG

Hydroxychloroquine, Clindamycin, Primaquine - low dose.

FMTVDM Planar, SPECT, PET

DRUG

Hydroxychloroquine, Clindamycin, Primaquine - high dose.

FMTVDM Planar, SPECT, PET

DRUG

Remdesivir

FMTVDM Planar, SPECT, PET

DRUG

Tocilizumab

FMTVDM Planar, SPECT, PET

DRUG

Methylprednisolone

FMTVDM Planar, SPECT, PET

DRUG

Interferon-Alpha2B

FMTVDM Planar, SPECT, PET

DRUG

Losartan

FMTVDM Planar, SPECT, PET

DRUG

Convalescent Serum

FMTVDM Planar, SPECT, PET

Trial Locations (1)

90245

FHHI-OI-Camelot; QME, Los Angeles

All Listed Sponsors

lead

The Camelot Foundation

OTHER